You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: August 3, 2020

DrugPatentWatch Database Preview


➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for cefepime hydrochloride and what is the scope of freedom to operate?

Cefepime hydrochloride is the generic ingredient in five branded drugs marketed by B Braun, Acs Dobfar, Fosun Pharma, Hospira Inc, Qilu, Sagent Pharms Inc, Baxter Hlthcare, and Samson Medcl, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for cefepime hydrochloride. Nine suppliers are listed for this compound.

Recent Clinical Trials for CEFEPIME HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

The Methodist Hospital SystemPhase 4
Yasser Esmat MohammedPhase 2/Phase 3
Assiut UniversityPhase 2/Phase 3

See all CEFEPIME HYDROCHLORIDE clinical trials


US Patents and Regulatory Information for CEFEPIME HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sagent Pharms Inc CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 091048-001 Jan 4, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Samson Medcl CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER cefepime hydrochloride POWDER;INTRAVENOUS 209408-001 Aug 21, 2018 RX No No   Start Trial   Start Trial   Start Trial
Hospira Inc MAXIPIME cefepime hydrochloride INJECTABLE;INJECTION 050679-002 Jan 18, 1996 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.